{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:07:13Z","timestamp":1787504833139,"version":"build-2736575974"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.japh.2020.01.002","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T20:34:42Z","timestamp":1581539682000},"page":"e70-e75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Implementing a pharmacist-run Lyme disease postexposure prophylaxis clinic augmented by academic detailing within the Veterans Health Administration"],"prefix":"10.1016","volume":"60","author":[{"given":"David B.","family":"Portman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.japh.2020.01.002_bib1","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1016\/j.japh.2020.01.002_bib2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.15585\/mmwr.mm6717e1","article-title":"Vital Signs: trends in reported vectorborne disease cases\u2013United States and territories, 2004-2016","volume":"67","author":"Rosenberg","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.japh.2020.01.002_bib5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(95)99915-9","article-title":"The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans","volume":"100","author":"Nadelman","year":"1996","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.japh.2020.01.002_bib6","first-page":"181","article-title":"The integral role of the clinical pharmacist practitioner in primary care","volume":"78","author":"Scott","year":"2017","journal-title":"N\u00a0C Med J"},{"key":"10.1016\/j.japh.2020.01.002_bib8","doi-asserted-by":"crossref","unstructured":"McFarland MS, Nelson J, Ourth H, Groppi J, Morreale A. Optimizing the primary care clinical pharmacy specialist: increasing patient access and quality of care within the Veterans Health administration [e-pub ahead of print]. J Am Coll Clin Pharm. https:\/\/doi.org\/10.1002\/jac5.1177. Accessed December 18, 2019.","DOI":"10.1002\/jac5.1177"},{"issue":"3","key":"10.1016\/j.japh.2020.01.002_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jama.2016.18764","article-title":"A\u00a0framework for disseminating clinical best practices in the VA health system","volume":"317","author":"Elnahal","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.japh.2020.01.002_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/M15-3058","article-title":"Pharmacist-led chronic disease management: a systematic review of effectiveness and harms compared with usual care","volume":"165","author":"Greer","year":"2016","journal-title":"Ann Intern Med"},{"issue":"17","key":"10.1016\/j.japh.2020.01.002_bib12","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.2016.4151","article-title":"Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011","volume":"315","author":"Fleming-Dutra","year":"2016","journal-title":"JAMA"},{"issue":"34","key":"10.1016\/j.japh.2020.01.002_bib13","first-page":"1153","article-title":"Office-related antibiotic prescribing for persons aged \u2264 14 years\u2013United States, 1993-1994 to 2007-2008","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.japh.2020.01.002_bib14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1542\/pir.35.12.500","article-title":"Borrelia burgdorferi (Lyme disease)","volume":"35","author":"Shapiro","year":"2014","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.japh.2020.01.002_bib15","article-title":"United States Department of Veterans Affairs","year":"2019","journal-title":"United States Department of Veterans Affairs"},{"issue":"24","key":"10.1016\/j.japh.2020.01.002_bib17","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM198306163082406","article-title":"Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based \u201cdetailing.\u201d","volume":"308","author":"Avorn","year":"1983","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.japh.2020.01.002_bib18","first-page":"CD000409","article-title":"Educational outreach visits: effects on professional practice and health care outcomes","author":"O\u2019Brien","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.japh.2020.01.002_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1331\/JAPhA.2014.13106","article-title":"Pharmacist initiation of postexposure doxycycline for Lyme disease prophylaxis","volume":"54","author":"Jackson","year":"2014","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2020.01.002_bib21","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1186\/1471-2458-12-918","article-title":"Attrition and generalizability in longitudinal studies: findings from a 15-year population-based study and a Monte Carlo simulation study","volume":"12","author":"Gustavson","year":"2012","journal-title":"BMC Public Health"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120300066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120300066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:46:45Z","timestamp":1761544005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319120300066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1544319120300066"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2020.01.002","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementing a pharmacist-run Lyme disease postexposure prophylaxis clinic augmented by academic detailing within the Veterans Health Administration","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2020.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}